Timing of RRT initiation in critically-ill patients: Time for precision medicine

Journal of Thoracic Disease

Volumn 8, Issue 10, 2016, Pages E1242-E1243

  Kipnis, Eric ^a   Garzotto, Francesco ^b   Ronco, Claudio ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EDITORIAL; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LUNG EDEMA; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PERSONALIZED MEDICINE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

EID: 84995486917     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2016.10.47     Document Type: Editorial

References (14)

1. Gaudry S, Hajage D, Schortgen F, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med 2016;375:122-33
2. Zarbock A, Kellum JA, Schmidt C, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA 2016;315:2190-9
3. Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008;12:R74
4. Teixeira C, Garzotto F, Piccinni P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013;17:R14
5. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009;76:422-7
6. Garzotto F, Ostermann M, Martín-Langerwerf D, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care 2016;20:196
7. Ostermann M, Joannidis M, Pani A, et al. Patient Selection and Timing of Continuous Renal Replacement Therapy. Blood Purif 2016;42:224-37
8. Murugan R, Hoste E, Mehta RL, et al. Precision Fluid Management in Continuous Renal Replacement Therapy. Blood Purif 2016;42:266-78
9. Kellum JA, Ronco C. The 17th Acute Disease Quality Initiative International Consensus Conference: Introducing Precision Renal Replacement Therapy. Blood Purif 2016;42:221-3
10. Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision Continuous Renal Replacement Therapy and Solute Control. Blood Purif 2016;42:238-47
11. Cerdá J, Baldwin I, Honore PM, et al. Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy. Blood Purif 2016;42:248-65
12. Camussi G, Ronco C, Montrucchio G, et al. Role of soluble mediators in sepsis and renal failure. Kidney Int Suppl 1998;66:S38-42
13. Cruz DN, Perazella MA, Bellomo R, et al. Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Kidney Dis 2006;48:361-71
14. Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 2009;37:2576-82